The median interval between the bariatric procedure and the initiation of pharmacological treatment was 5 years (IQR: 27 years)
Less common but more serious risks include: Pancreatitis, which can cause severe abdominal pain and may require stopping the medication Gallbladder problems, such as gallstones or inflammation, especially with higher doses or longer use Allergic reactions, including swelling or difficulty breathing, which need immediate medical attention Injection site reactions, such as redness or itching, with injectable forms Rare vision changes or worsening diabetic eye disease, especially when blood sugar improves rapidly Anyone with intense abdominal pain, signs of dehydration (such as dizziness or reduced urination), or unexpected vision changes should seek medical advice promptly

When to Call Your Doctor Immediately: Seek immediate medical attention if you experience any of the following: Severe abdominal pain Persistent vomiting Signs of an allergic reaction (shortness of breath, wheezing, hives) Symptoms of pancreatitis Yellowing of the skin or eyes Severe or persistent hypoglycemia GLP-1 and the Indian Diet: What to Eat, What to Avoid One of the biggest concerns for Indian patients is how GLP-1 medications fit into their traditional diet
They work
Most common AEs were gastrointestinal, and of mild or moderate severity (Table 2)
Compounded Tirzepatide From a 503B Pharmacy There are two categories of compounding pharmacy in the U.S